Experimentation of Heterocycles (2013‐22) as Potent Pharmacophores in Drug Design of Multiple Sclerosis

Documenti analoghi

• Design and Synthesis of Novel Lonidamine‐N‐Heterocyclic Derivatives With Potent Anticancer Activity Against Colorectal Cancer Cells
  di: Raveendra Madhukar Bhat, et al.
  Pubblicazione: (2026)
• Heterocyclic Scaffold Modification of Chalcones: Piperidinyl and Morpholinyl Triazene Derivatives as Potent Blood Stage Antimalarials With SAR and Docking Insights
  di: Ahammed Ameen Thottasseri, et al.
  Pubblicazione: (2026)
• Design, Synthesis, and Biological Evaluation of Potent FLT3 Inhibitor for Acute Myeloid Leukemia (AML) Treatment
  di: Kun Du, et al.
  Pubblicazione: (2025)
• Bioinformatics Exploration of the Therapeutic Potential of Lotus Seed Compounds in Multiple Sclerosis: A Network Analysis of c‐Jun Pathway
  di: Rapuru Rushendran, et al.
  Pubblicazione: (2025)
• Discovery of Tetrahydropyrrolo[3,4‐c]pyrrole‐1,3‐dione Derivatives as Novel RIPK1 Inhibitors via Pharmacophore‐Based Virtual Screening
  di: Xin Zeng, et al.
  Pubblicazione: (2026)